October 08, 2018
Newly Published Data in Nature Medicine Show Potential of mRNA to Produce Therapeutic and Protective Protein Levels in Pre-Clinical Models of Acute Intermittent Porphyria
September 05, 2018
Dr. Wellington Sun Joins Moderna as Head, Vaccine Strategy and Regulatory Affairs
July 17, 2018
Moderna Opens New Manufacturing Site in Norwood, MA
July 11, 2018
Moderna Provides Mid-Year Corporate Update
June 14, 2018
Former Akamai CEO Paul Sagan Joins Moderna’s Board of Directors
May 03, 2018
Moderna and Merck Expand mRNA Cancer Vaccines Collaboration
April 24, 2018
Lori Henderson Joins Moderna as General Counsel and Corporate Secretary
April 04, 2018
Megan Pace Joins Moderna as Chief Corporate Affairs Officer
February 20, 2018
Newly Published Data Highlight Moderna’s mRNA Platform in Advancing Prophylactic Vaccine for Cytomegalovirus (CMV) Infections
February 01, 2018
Moderna Closes $500 Million Equity Financing